1.
Cardiovascular risk prediction: are we there yet?
by Jackson, Rod
Heart (British Cardiac Society), 2008, Vol.94 (1), p.1-3
2.
Beyond disease burden: towards solution-oriented population health
by Roberts, Ian, Prof
The Lancet (British edition), 2013, Vol.381 (9884), p.2219-2221
3.
Treating individuals 5: treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005, Vol.365 (9457), p.434
4.
HbA 1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline
by Metcalf, Patricia Anne
Journal of diabetes and its complications, 2017, Vol.31 (5), p.814-823
5.
Alcohol and ischaemic heart disease: probably no free lunch
by Jackson, Rod
The Lancet (British edition), 2005, Vol.366 (9501), p.1911-1912
6.
HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline
by Metcalf, PA
Journal of diabetes and its complications, 2017, Vol.31 (5), p.814-823
7.
Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2)
by Grey, Corina
Heart (British Cardiac Society), 2014, Vol.100 (10), p.770-774
8.
Blood pressure lowering and cardiovascular risk – Authors' reply
by Sundström, Johan
The Lancet (British edition), 2014, Vol.384 (9956), p.1746-1747
9.
Attributing Risk to Hypertension: What Does it Mean?
by Jackson, Rod
American journal of hypertension, 2009, Vol.22 (3), p.237-238
10.
Dietary guidelines on trial: the charges are not evidence based
by Mann, Jim
The Lancet (British edition), 2016, Vol.388 (10047), p.851-853
11.
‘Your Heart Forecast’: a new approach for describing and communicating cardiovascular risk?
by Wells, Susan
Heart (British Cardiac Society), 2010, Vol.96 (9), p.708-713
12.
Prevalence of sleepiness while driving four-wheel motor vehicles in Fiji: a population-based survey (TRIP 9)
by Herman, Josephine
Injury prevention, 2013, Vol.19 (4), p.271-19
13.
Alcohol and ischaemic heart disease – Authors' reply
by Jackson, Rod
The Lancet (British edition), 2006, Vol.367 (9514), p.902-902
14.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014, Vol.384 (9943), p.591-598
15.
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk
by Jackson, Rod
The Lancet (British edition), 2005, Vol.365 (9457), p.434-441
16.
HbA.sub.1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline
by Metcalf, Patricia Anne
Journal of diabetes and its complications, 2017, Vol.31 (5), p.814
17.
Debate: to treat or not to treat mild hypertension
by Jackson, Rod
American journal of hypertension, 2000, Vol.13 (4), p.316A-317A
18.
Blood pressure lowering and cardiovascular risk reply
by Sundström, Johan
The Lancet (British edition), 2014, Vol.384 (9956), p.1746
19.
The contribution of alcohol to falls at home among working-aged adults
by Kool, Bridget
Alcohol (Fayetteville, N.Y.), 2008, Vol.42 (5), p.383-388
20.
The GATE frame: critical appraisal with pictures
by Jackson, Rod
Evidence-based nursing, 2006, Vol.9 (3), p.68-71
